Physician profile
Stephen E Brown
NPI 1275709651
$5,244.92
in general payments reported to CMS, 2019-2025
17 companies · $955 in 2025
The $955 reported for 2025 was more than what 80% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $782 · 2020: $634 · 2021: $700 · 2022: $747 · 2023: $913 · 2024: $514 · 2025: $955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,382.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,125.64 | 2021-2025 | Vraylar |
| Otsuka America Pharmaceutical, INC. | $750.02 | 2019-2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $589.37 | 2024-2025 | Fanapt, Hetlioz |
| Takeda Pharmaceuticals U.S.A., INC. | $533.20 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $494.34 | 2022-2025 | Ingrezza |
| Sunovion Pharmaceuticals INC. | $470.68 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $223.38 | 2022-2025 | Caplyta |
| Allergan, INC. | $223.14 | 2020 | |
| Axsome Therapeutics, INC. | $212.15 | 2023-2024 | Auvelity |
| Idorsia Pharmaceuticals US INC | $147.79 | 2023 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $136.77 | 2023 | Austedo Xr |
| Janssen Pharmaceuticals, INC | $114.76 | 2019 | |
| Lundbeck LLC | $60.21 | 2021-2023 | Rexulti |
| Shire North American Group INC | $55.75 | 2019 | |
| Corium, LLC | $50.05 | 2022-2023 | Azstarys |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $35.81 | 2021 | |
| Jazz Pharmaceuticals INC. | $21.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.